Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Stotz

Showing results (11-20 of 59) with videos related to

Pageof 6
Sort By:
British Journal of Cancer|December 2, 2016
Critical evaluation of the potential prognostic value of the pretreatment-derived neutrophil-lymphocyte ratio under consideration of C-reactive protein levels in clear cell renal cell carcinomaOrietta Dalpiaz, Theresa Luef, Maximilian Seles, et al.
Plos One|September 11, 2014
Pre-treatment anemia is a poor prognostic factor in soft tissue sarcoma patientsJoanna Szkandera, Armin Gerger, Bernadette Liegl-Atzwanger, et al.
American Journal of Surgery|January 15, 2015
The derived neutrophil/lymphocyte ratio predicts poor clinical outcome in soft tissue sarcoma patientsJoanna Szkandera, Armin Gerger, Bernadette Liegl-Atzwanger, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|April 4, 2013
A common gene variant in PLS3 predicts colon cancer recurrence in womenJoanna Szkandera, Thomas Winder, Michael Stotz, et al.
Molecular Carcinogenesis|April 30, 2013
A common and functional gene variant in the vascular endothelial growth factor a predicts clinical outcome in early-stage breast cancerGudrun Absenger, Joanna Szkandera, Michael Stotz, et al.
Anticancer Research|January 9, 2021
The AST/ALT Ratio Is an Independent Prognostic Marker for Disease-free Survival in Stage II and III Colorectal CarcinomaLukas Scheipner, Maria Anna Smolle, Dominik Barth, et al.
Anticancer Research|July 31, 2012
The functional polymorphism of erythropoietin gene rs1617640 G>T is not associated with susceptibility and clinical outcome of early-stage breast cancerJoanna Szkandera, Gudrun Absenger, Michael Stotz, et al.
Plos One|July 26, 2016
Blood-Based Biomarkers Are Associated with Disease Recurrence and Survival in Gastrointestinal Stroma Tumor Patients after Surgical ResectionMichael Stotz, Bernadette Liegl-Atzwanger, Florian Posch, et al.
International Journal of Molecular Sciences|September 9, 2016
Current Status of Long Non-Coding RNAs in Human Breast CancerStefanie Cerk, Daniela Schwarzenbacher, Jan Basri Adiprasito, et al.
Clinical Chemistry and Laboratory Medicine|October 18, 2014
Uric acid levels in blood are associated with clinical outcome in soft-tissue sarcoma patientsJoanna Szkandera, Armin Gerger, Bernadette Liegl-Atzwanger, et al.
Pageof 6

Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
British Journal of Cancer|December 2, 2016
Critical evaluation of the potential prognostic value of the pretreatment-derived neutrophil-lymphocyte ratio under consideration of C-reactive protein levels in clear cell renal cell carcinomaOrietta Dalpiaz, Theresa Luef, Maximilian Seles, et al.
Plos One|September 11, 2014
Pre-treatment anemia is a poor prognostic factor in soft tissue sarcoma patientsJoanna Szkandera, Armin Gerger, Bernadette Liegl-Atzwanger, et al.
American Journal of Surgery|January 15, 2015
The derived neutrophil/lymphocyte ratio predicts poor clinical outcome in soft tissue sarcoma patientsJoanna Szkandera, Armin Gerger, Bernadette Liegl-Atzwanger, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|April 4, 2013
A common gene variant in PLS3 predicts colon cancer recurrence in womenJoanna Szkandera, Thomas Winder, Michael Stotz, et al.
Molecular Carcinogenesis|April 30, 2013
A common and functional gene variant in the vascular endothelial growth factor a predicts clinical outcome in early-stage breast cancerGudrun Absenger, Joanna Szkandera, Michael Stotz, et al.
Anticancer Research|January 9, 2021
The AST/ALT Ratio Is an Independent Prognostic Marker for Disease-free Survival in Stage II and III Colorectal CarcinomaLukas Scheipner, Maria Anna Smolle, Dominik Barth, et al.
Anticancer Research|July 31, 2012
The functional polymorphism of erythropoietin gene rs1617640 G>T is not associated with susceptibility and clinical outcome of early-stage breast cancerJoanna Szkandera, Gudrun Absenger, Michael Stotz, et al.
Plos One|July 26, 2016
Blood-Based Biomarkers Are Associated with Disease Recurrence and Survival in Gastrointestinal Stroma Tumor Patients after Surgical ResectionMichael Stotz, Bernadette Liegl-Atzwanger, Florian Posch, et al.
International Journal of Molecular Sciences|September 9, 2016
Current Status of Long Non-Coding RNAs in Human Breast CancerStefanie Cerk, Daniela Schwarzenbacher, Jan Basri Adiprasito, et al.
Clinical Chemistry and Laboratory Medicine|October 18, 2014
Uric acid levels in blood are associated with clinical outcome in soft-tissue sarcoma patientsJoanna Szkandera, Armin Gerger, Bernadette Liegl-Atzwanger, et al.
Pageof 6